Cargando…
Association between serum iron markers, iron supplementation and cardiovascular morbidity in pre-dialysis chronic kidney disease
BACKGROUND: The optimal range of serum iron markers and usefulness of iron supplementation are uncertain in patients with pre-dialysis chronic kidney disease (CKD). We investigated the association between serum iron indices and risk of cardiovascular disease (CVD) events and the effectiveness of iro...
Autores principales: | Hasegawa, Takeshi, Imaizumi, Takahiro, Hamano, Takayuki, Murotani, Kenta, Fujii, Naohiko, Komaba, Hirotaka, Ando, Masahiko, Maruyama, Shoichi, Nangaku, Masaomi, Nitta, Kosaku, Hirakata, Hideki, Isaka, Yoshitaka, Wada, Takashi, Fukagawa, Masafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689172/ https://www.ncbi.nlm.nih.gov/pubmed/37202214 http://dx.doi.org/10.1093/ndt/gfad096 |
Ejemplares similares
-
Biopsy-proven CKD etiology and outcomes: the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
por: Hamano, Takayuki, et al.
Publicado: (2022) -
Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
por: Komaba, Hirotaka, et al.
Publicado: (2021) -
Thresholds of iron markers for iron deficiency erythropoiesis—finding of
the Japanese nationwide dialysis registry
por: Hamano, Takayuki, et al.
Publicado: (2015) -
Acute cardiac overload does not induce cardiac or skeletal expression of fibroblast growth factor 23 in rats
por: Fajol, Abul, et al.
Publicado: (2021) -
Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention
por: Goto, Shunsuke, et al.
Publicado: (2008)